Table 4.
Samples | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
---|---|---|---|---|---|---|---|---|---|---|
Brain laterality | R | R | L | L | L | L | R | L | R | L |
Methylation status | M | M | M | M | U | U | U | U | U | M |
Relative expression of MB-COMT | 0.84 | 1.15 | 0.5 | 0.87 | 2.45 | 2.3 | 4.6 | 2.3 | 4.6 | 1.7 |
Relative fold change | Controls = 1.16 (SD = 0.76) | SCZ = 3.1 (SD = 1.4) | ||||||||
Patients versus controls | (t = −2.74, P = 0.026) |
R, right; L, left; M, methylated; U, unmethylated.
Samples 1–5 are from controls and 6–10 from schizophrenic patients. CT value was used for relative quantitation of MB-COMT expression (normalized to GADPH gene expression as an internal control). Fold changes was calculated as 2–△△CT.